Promethera Therapeutics, Société anonyme

H2STEM

Pharmaceutical and veterinary preparations of human adult hepatocytes for the treatment of heavy to life-threatening liver and cellular diseases as well as for metabolism diseases of the liver;H 2 STEM; H TWO STEM;Medical and veterinary services; medical services relating to the removal, treatment and processing of stem cells; therapy services, namely, stem cell therapy services for medical and veterinary treatment purposes;Scientific and technological services and research and design relating thereto, namely, biological research and scientific research in the field of biotechnology; pharmaceutical and veterinary research services; development of pharmaceutical and veterinary products; medical laboratory services;

H2STEM

Cells for medical use, namely, stem cells for medical purposes, progenitor cells for medical purposes;H TWO STEM;

HEPARESC

Pharmaceutical and veterinary preparations, in particular pharmaceuticals of human adult hepatocytes for the treatment of heavy to life-threatening liver and cellular diseases as well as for metabolism diseases of the liver; all of the foregoing pharmaceutical preparations not for distribution in pharmacies and not as over-the-counter-drugs;Medical and veterinary services; healthcare for humans and animals, in particular therapy of the human or animal body with hepatocytes; medical advice in the examination and analysis of hepatocytes and in the production of pharmaceuticals;Scientific and technological services and research activities, in particular the examination of hepatic tissue and pharmaceuticals; industrial analysis and research services, in particular the analysis of hepatic tissue and pharmaceuticals;

HEPASTEM

Cells originating from the liver, for medical, clinical or veterinary use, in particular liver stem cells or progenitor cells; pharmaceutical preparations for the treatment of liver diseases that require cell therapy medicinal products;Biomedical services for diagnosing and treating liver disease in relation to the testing of biological samples to determine the presence and activity of liver cells, in particular, liver stem cells and progenitor cells; medical and veterinary services for the isolation, analysis, processing, and administration of cells originating from the liver and in particular, liver stem cells and progenitor cells for diagnosing and treating liver disease;Scientific and biotechnological medical research for the pharmaceutical and health care industry relating to development of new medicinal products for cell therapy; scientific and biotechnological medical research for the pharmaceutical and healthcare industry relating to the new product design, validation in the form of quality control, and development of application methods for using cells, in particular, liver stem cells and progenitor cells; development of methods for storage and transport of cells, in particular, liver stem cells and progenitor cells;

PROMETHERA

The mark consists of a design of four cells where three of the cells are in light grey and one is in red. To the right of the cells is the word PROMETHERA where the letters PROME are in red and the letters THERA are in dark grey.;Pharmaceutical and veterinary preparations of human adult hepatocytes for the treatment of heavy to life-threatening liver and cellular diseases as well as for metabolism diseases of the liver;PROME THERA;The color(s) light grey, red and dark grey is/are claimed as a feature of the mark.;Medical and veterinary services; medical services relating to the removal, treatment and processing of stem cells; therapy services, namely, stem cell therapy services for medical and veterinary treatment purposes;Scientific and technological services and research and design relating thereto, namely, biological research and scientific research in the field of biotechnology; pharmaceutical and veterinary research services; development of pharmaceutical and veterinary products; medical laboratory services;